Keyphrases
Acute Myocardial Infarction
100%
Randomized Clinical Trial
100%
Myocardial Infarction Patients
100%
Primary Percutaneous Coronary Intervention
100%
Danegaptide
100%
ST-elevation Myocardial Infarction (STEMI)
33%
Myocardial Salvage
25%
Clinical Outcomes
8%
Therapeutic Potential
8%
Placebo
8%
High Dose
8%
Small Vessel Disease
8%
Trial Registration
8%
Between-group
8%
Left Ventricular Ejection Fraction
8%
Gap Junction
8%
Imaging Criteria
8%
Proof of Concept Study
8%
Ischemic Insult
8%
Dose Level
8%
Cardiac Magnetic Resonance Imaging (cMRI)
8%
Ischemia-reperfusion Injury
8%
Myocardial Injury
8%
Final Infarct Size
8%
Two-dose
8%
Reperfusion
8%
Infarct-related Artery
8%
Myocardial Salvage Index
8%
Thrombolysis in Myocardial Infarction Flow
8%
Per-protocol Analysis
8%
Ischemic Time
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
100%
Randomized Clinical Trial
100%
Danegaptide
100%
ST Segment Elevation Myocardial Infarction
33%
Infarction
16%
Heart Infarction
8%
Disease
8%
Placebo
8%
Injury
8%
Ischemia
8%
Reperfusion Injury
8%
Heart Muscle Injury
8%
Biochemistry, Genetics and Molecular Biology
ST Elevation
100%
Randomized Clinical Trial
100%
Reperfusion
50%
Heart Left Ventricle Ejection Fraction
25%
Animal Model
25%
Low Drug Dose
25%
Drug Megadose
25%
Blood Clot Lysis
25%